Oct. 20, 2005 (Montreal) — A transdermal cream formulation of alprostadil may be an effective treatment for female sexual arousal disorder (FSAD), according to phase 2 research. Alprostadil is a ...
The FDA has not approved any medicated creams for treating ED, and has issued warnings about products making such claims. Vitaros, a cream containing alprostadil, is approved in Canada and Europe but ...
May 25, 2012 (Atlanta, Georgia) — A new formulation of alprostadil cream 0.4% (Femprox, Apricus Biosciences Inc), administered topically, significantly improved symptoms of female sexual arousal ...
Retention and migration of a specially designed alprostadil transdermal cream was assessed after single-dose administration to the glans meatus of the penis. Seven men were enrolled in this two-way ...
Ferring Pharmaceuticals purchased ex-U.S. assets and rights to Apricus Biosciences’ on-demand topical erectile dysfunction therapy cream Vitaros ® (alprostadil) for potentially $12.7 million. Ferring ...
Overview: Alprostadil is used to diagnose and treat erectile dysfunction (ED). The most common side effect with alprostadil is penis pain. Serious side effects are rare but can include an unwanted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results